Depomed Has Returned 32.1% Since SmarTrend Recommendation (DEPO)
Comtex SmarTrend(R) - Mon Dec 22, 9:11AM CST
SmarTrend identified an Uptrend for Depomed (NASDAQ
DEPO: 15.54 (+0.38)
Depomed Shares Up 22.8% Since SmarTrend's Buy Recommendation (DEPO)
Comtex SmarTrend(R) - Fri Dec 12, 4:50PM CST
SmarTrend identified an Uptrend for Depomed (NASDAQ
DEPO: 15.54 (+0.38)
Depomed Products Are Broadly Covered For 2015
Clinically Sound Investor - at Seeking Alpha - Fri Dec 12, 9:33AM CST
DEPO: 15.54 (+0.38)
Shares of DEPO Up 30.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Dec 05, 11:06AM CST
SmarTrend identified an Uptrend for Depomed (NASDAQ
DEPO: 15.54 (+0.38)
Market Movers - Pharma Industry Stocks - Hospira, Perrigo, Auxilium Pharma, Depomed, and Endo Intl.
PR Newswire - Mon Dec 01, 8:05AM CST
Investor-Edge has initiated coverage on the following equities: Hospira Inc. (NYSE: HSP), Perrigo Company PLC (NYSE: PRGO), Auxilium Pharmaceuticals Inc. (NASDAQ: AUXL), Depomed Inc. (NASDAQ: DEPO), and Endo International PLC (NASDAQ: ENDP). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Friday, November 28, 2014, ended on a mixed note as the Dow Jones Industrial Average finished flat at 17,828.24 and the NASDAQ Composite closed at 4,791.63, up 0.09%. The S&P 500 finished the session 0.25% lower at 2,067.56. During the trading session, seven out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 803.65, up 0.58%, with the index advancing 8.95% in the previous three months. Register for your complimentary reports on these five stocks at:
ENDP: 72.10 (+0.34), PRGO: 166.11 (+1.96), AUXL: 34.40 (+0.18), DEPO: 15.54 (+0.38), HSP: 62.60 (-0.07)
Depomed Up 22.9% Since SmarTrend Uptrend Call (DEPO)
Comtex SmarTrend(R) - Thu Nov 20, 4:48PM CST
SmarTrend identified an Uptrend for Depomed (NASDAQ
DEPO: 15.54 (+0.38)
Depomed To Present At Piper Jaffray 26th Annual Healthcare Conference
PR Newswire - Thu Nov 20, 3:05PM CST
Depomed, Inc. (NASDAQ
DEPO: 15.54 (+0.38)
How 7% Yielding PDL BioPharma Is Reinventing Itself
David Zanoni - at Seeking Alpha - Wed Nov 12, 7:26AM CST
DEPO: 15.54 (+0.38), PDLI: 7.61 (unch)
Depomed To Present At Stifel 2014 Healthcare Conference
PR Newswire - Wed Nov 12, 7:00AM CST
Depomed, Inc. (NASDAQ
DEPO: 15.54 (+0.38)
INVESTOR ALERT: Class Action Lawsuit Against PDL BioPharma, Inc. Announced by Law Offices of Howard G. Smith
Business Wire - Mon Nov 10, 2:32PM CST
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed in the United States District Court for the District of Nevada on behalf of purchasers of the securities of PDL BioPharma, Inc. ("PDL BioPharma" or the "Company"
DEPO: 15.54 (+0.38), PDLI: 7.61 (unch)
DepoMed's (DEPO) CEO James Schoeneck on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 05, 6:30PM CST
DEPO: 15.54 (+0.38)
Depomed beats Street 3Q forecasts
Automated Insights - Wed Nov 05, 4:42PM CST
NEWARK, Calif. (AP) _ Depomed Inc. (DEPO) on Wednesday reported third-quarter earnings of $6.5 million.
DEPO: 15.54 (+0.38)
Depomed beats by $0.07, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 3:47PM CST
DEPO: 15.54 (+0.38)
Depomed (DEPO) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Nov 05, 3:25PM CST
DEPO: 15.54 (+0.38)
Depomed Reports Third Quarter 2014 Financial Results
PR Newswire - Wed Nov 05, 3:05PM CST
Depomed, Inc. (Nasdaq: DEPO) today reported financial results and highlighted operational achievements for the quarter ended September 30, 2014.
DEPO: 15.54 (+0.38)
Notable earnings after Wednesday’s close
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 4:35PM CST
CXO: 99.86 (-0.04), CODI: 15.99 (-0.11), EXXI: 3.45 (-0.22), JCOM: 63.12 (-0.46), ATSG: 8.68 (-0.10), GPOR: 42.09 (+0.38), ENS: 61.66 (+0.36), ECYT: 6.33 (+0.24), ALNY: 93.52 (+0.97), KGC: 2.70 (+0.11), GSM: 16.23 (+0.24), BKD: 36.16 (-0.07), DK: 27.12 (-0.10), AR: 42.50 (-0.64), IL: 11.44 (-0.01), DVR: 0.14 (-0.08), IO: 2.80 (+0.05), DEPO: 15.54 (+0.38), ETE: 57.05 (+0.03), AVG: 20.25 (+0.18), CSOD: 36.66 (-0.14), GNW: 8.40 (+0.01), ECOL: 39.67 (-0.07), BWC: 30.30 (-0.16), CPE: 5.39 (+0.02), FNV: 48.03 (+1.22), CTL: 40.18 (-0.05), ASH: 119.40 (-0.48), ENSG: 45.38 (+0.01), CLR: 38.78 (-1.48), ACAS: 14.95 (+0.12), G: 19.18 (unch), BREW: 13.79 (+0.01), AWK: 53.76 (+0.59), CVG: 20.51 (-0.01), AREX: 6.98 (-0.11), HTCH: 3.60 (unch), ETP: 63.95 (+0.35), ABTL: 11.24 (-0.04), FMI: 23.99 (-0.10), DPM: 45.60 (+0.36), BCOR: 13.90 (-0.03), CDE: 5.11 (+0.31), DRYS: 1.20 (-0.04), KW: 25.58 (-0.07), BALT: 2.47 (-0.11), ATO: 55.58 (+0.90), EXAR: 10.35 (+0.19), ACLS: 2.47 (+0.04), INWK: 7.82 (-0.04), ALSK: 1.82 (-0.05), CF: 275.49 (-3.16), EFC: 20.20 (-0.55), BIOS: 6.37 (unch), DYN: 29.42 (+0.12), DATA: 88.76 (+0.04), ANDE: 55.10 (+0.35), HOLX: 26.89 (+0.10), CBS: 55.70 (-0.13)
23.7% Return Seen to Date on SmarTrend Depomed Call (DEPO)
Comtex SmarTrend(R) - Thu Oct 30, 9:18AM CDT
SmarTrend identified an Uptrend for Depomed (NASDAQ
DEPO: 15.54 (+0.38)